Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr
Clinical trial NCT00648414 · TERMINATED
Trial details
- NCT number
- NCT00648414
- Sponsor
- Mylan Pharmaceuticals Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2006-10-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.